SKIP TO CONTENT
The U.S. Environmental Protection Agency (EPA) announced on January 19, 2023, the availability of and solicited public comment on a draft white paper entitled “Availability of New Approach Methodologies (NAMs) in the Endocrine Disruptor Screening Program (EDSP).” 88 Fed. Reg. 3406. EPA states that it developed the draft white paper pursuant to the Federal, Food, Drug, and Cosmetic Act (FFDCA), which requires EPA to develop a screening program to determine whether certain substances may...
By Lynn L. Bergeson and Carla N. Hutton The European Chemicals Agency (ECHA) is holding a public consultation on a harmonized classification and labeling (CLH) proposal for a biocidal active substance, 3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate (IPBC) (European Community Number (EC No.) 259-627-5, Chemical Abstracts Service Registry Number® (CAS RN®) 55406-53-6). ECHA used a combined format, including the...
January 23, 2023
EPA Announces Next Test Order Issued under National Testing Strategy for PFAS Used in Plastics, Chemical Manufacturing
The U.S. Environmental Protection Agency (EPA) announced on January 4, 2023, that it issued the next Toxic Substances Control Act (TSCA) test order requiring testing on per- and polyfluoroalkyl substances (PFAS) under its National PFAS Testing Strategy. The test order requires companies to conduct and submit testing on trifluoro(trifluoromethyl)oxirane (HFPO), a perfluoroalkyl substance used in making plastics. EPA states that this is “the second test order under the strategy...
January 19, 2023
Recording Available For “Two Years Later: How Has the Chemicals Strategy for Sustainability Changed REACH and CLP Regulations?”
The Acta Group's (Acta®) January 17, 2023, webinar, “Two Years Later: How Has the Chemicals Strategy for Sustainability Changed REACH and CLP Regulations?,” is now available for on-demand viewing. During this one-hour webinar Meglena Mihova, Managing Partner, EPPA; Thomas Petry, Ph.D., Managing Director, ToxMinds; Jane S. Vergnes, Ph.D., DABT®, Vice President, Scientific Affairs, Director of Toxicology, Acta; and Lynn L. Bergeson, President, Acta, explore exactly...
Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are pleased to announce the following hirings and promotions. Catherine M. Croke, DBA, has been named Director of Product Stewardship and Regulatory Affairs. Dr. Croke is a highly experienced professional with more than three decades of successfully developing and executing product stewardship and regulatory compliance programs within global specialty chemicals and materials...
January 19, 2023
EPA Finds TCE, as a Whole Chemical Substance, Poses an Unreasonable Risk to Human Health
The U.S. Environmental Protection Agency (EPA) announced on January 9, 2023, the availability of the final revision to the risk determination for trichloroethylene (TCE) risk evaluation issued under the Toxic Substances Control Act (TSCA). 88 Fed. Reg. 1222. EPA determined that TCE, as a whole chemical substance, presents an unreasonable risk of injury to human health when evaluated under its conditions of use (COU). EPA states that the revision to the risk determination reflects its...
January 18, 2023
Acta Webinar on Chemicals Strategy for Sustainability Quoted in Bloomberg Law Article “Chemical Law Change Ahead in EU Seen Likely to Raise Costs in US”
On January 17, 2023, Bloomberg Law quoted speakers, including Jane S. Vergnes, Ph.D., DABT®, Vice President, Scientific Affairs and Director of Toxicology, The Acta Group (Acta®), from Acta's "Two Years Later: How Has the Chemicals Strategy for Sustainability Changed REACH and CLP Regulations?" webinar. The European Union will propose many regulatory changes this year that could substantially increase US companies’ costs and prevent exports of...
January 18, 2023
Lynn L. Bergeson Quoted by Chemical Watch in Article “What should we expect from TSCA in 2023?”
On January 18, 2023, Chemical Watch quoted Lynn L. Bergeson, President, The Acta Group (Acta®), regarding changes expected from the U.S. Environmental Protection Agency (EPA) in the coming year. According to attorneys at Bergeson & Campbell, the EPA has pulled senior scientists from across the agency to assist with new chemicals reviews, while continuing to hire new ones. "The onboarding and training of new assessors will take time, but...
January 18, 2023
Congress Enacts Modernization of Cosmetics Regulation Act of 2022, Significantly Strengthening Regulation of Cosmetics
In a move that some may not have seen coming, Congress enacted the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) on December 29, 2022, as part of the Omnibus Appropriations Act. The MoCRA significantly strengthens the U.S. Food and Drug Administration (FDA) authority over cosmetic products. Key impacts are summarized below. Background On April 16, 2021, the Performance Enhancement Reform Act was introduced to the House of Representatives by Representative Gerald E....
January 17, 2023
Richard E. Engler, Ph.D., Quoted by Chemical Watch in Article “US speciality chemical firms considering shifting R&D to EU”
On January 17, 2023, Chemical Watch quoted Richard E. Engler, Ph.D., Director of Chemistry, The Acta Group (Acta®) regarding an annoucement by the Society of Chemical Manufacturers and Affiliates (Socma) that U.S. speciality chemicals companies are "strongly considering" introducing new chemicals into the European market due to the consistency of the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) review process relative to that of...